Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells. | Front Immunol | 2020 | 33335526 | PubTator, text mining | PubMed |
| Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report. | Front Oncol | 2020 | 33330104 | PubTator, text mining | PubMed |
| A Neutrophil-Driven Inflammatory Signature Characterizes the Blood Transcriptome Fingerprint of Psoriasis. | Front Immunol | 2020 | 33329570 | PubTator, text mining | PubMed |
| The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment. | Cancers (Basel) | 2020 | 33327433 | PubTator, text mining | PubMed |
| Prospects for NK Cell Therapy of Sarcoma. | Cancers (Basel) | 2020 | 33322371 | PubTator, text mining | PubMed |
| Insights on TAM Formation from a Boolean Model of Macrophage Polarization Based on In Vitro Studies. | Cancers (Basel) | 2020 | 33297362 | PubTator, text mining | PubMed |
| Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management. | Clin Proteomics | 2020 | 33292167 | PubTator, text mining | PubMed |
| Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire. | J Vis Exp | 2020 | 33283785 | PubTator, text mining | PubMed |
| Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome. | Int J Mol Sci | 2020 | 33271951 | PubTator, text mining | PubMed |
| Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and Metabolism. | Biomedicines | 2020 | 33266387 | PubTator, text mining | PubMed |
| Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. | Cancers (Basel) | 2020 | 33260693 | PubTator, text mining | PubMed |
| Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. | World J Gastrointest Oncol | 2020 | 33250959 | PubTator, text mining | PubMed |
| Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV). | Int J Mol Sci | 2020 | 33238550 | PubTator, text mining | PubMed |
| Standard treatment-refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin. | Clin Transl Immunology | 2020 | 33235734 | PubTator, text mining | PubMed |
| Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells. | Biomedicines | 2020 | 33228048 | PubTator, text mining | PubMed |
| Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation. | Genes Immun | 2020 | 33223527 | PubTator, text mining | PubMed |
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities. | Genome Med | 2020 | 33218352 | PubTator, text mining | PubMed |
| Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19. | Viruses | 2020 | 33218001 | PubTator, text mining | PubMed |
| Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA). | Transl Androl Urol | 2020 | 33209669 | PubTator, text mining | PubMed |
| Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit? | Cancers (Basel) | 2020 | 33207697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=53